Complete ICD-10-CM coding and documentation guide for Tuberculosis Testing. Includes clinical validation requirements, documentation requirements, and coding pitfalls.
Also known as:
Complete code families applicable to Tuberculosis Testing
Encounter for screening for infectious and parasitic diseases
This range includes codes for screening for tuberculosis, both active and latent.
Tuberculosis
This range includes codes for confirmed cases of tuberculosis, which may be relevant following a positive test.
Abnormal immunological findings in serum without diagnosis
This range includes codes for positive test results without a diagnosis of active disease.
Compare key differences between these codes to ensure accurate selection
Code | Description | When to Use | Key Documentation |
---|---|---|---|
Z11.1 | Encounter for screening for respiratory tuberculosis | Use when screening for active TB in symptomatic patients or as part of a public health measure. |
|
Z11.7 | Encounter for testing for latent tuberculosis infection | Use for asymptomatic patients undergoing testing for latent TB. |
|
R76.11 | Positive tuberculin skin test without active tuberculosis | Use when TST is positive but no active TB is diagnosed. |
|
R76.12 | Positive interferon gamma release assay without active tuberculosis | Use when IGRA is positive but no active TB is diagnosed. |
|
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Essential facts and insights about Tuberculosis Testing
Use for asymptomatic patients undergoing testing for latent TB.
Ensure documentation specifies the type of test and result.
Use when TST is positive but no active TB is diagnosed.
Document induration size and patient risk factors.
Use when IGRA is positive but no active TB is diagnosed.
Document quantitative IGRA result and patient risk factors.
Additional codes that should be used in conjunction with the main diagnosis codes when applicable.
Alternative codes to consider when ruling out similar conditions to the primary diagnosis.
Avoid these common documentation and coding issues when documenting Tuberculosis Testing to ensure proper reimbursement, maintain compliance, and reduce audit risk. These guidelines are particularly important when using ICD-10 code Z11.1.
Clinical: May lead to misinterpretation of TB status., Regulatory: Non-compliance with documentation standards., Financial: Potential claim denials due to insufficient documentation.
Use structured templates for documentation., Ensure all test results are recorded in detail.
Reimbursement: Incorrect coding may lead to denied claims., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate data on TB testing prevalence.
Use Z11.7 for latent TB testing in asymptomatic patients.
Reimbursement: Claims may be rejected due to incomplete coding., Compliance: Fails to meet coding standards., Data Quality: Incomplete data on TB screening outcomes.
Always pair R76.11 with Z11.7 for complete documentation.
Using Z11.1 instead of Z11.7 for latent TB testing.
Educate staff on correct code usage and provide decision support tools.
Documentation errors, coding pitfalls, and audit risks are interconnected aspects of medical coding and billing. Addressing all three areas helps ensure accurate coding, optimal reimbursement, and regulatory compliance.
Common questions about ICD-10 coding for Tuberculosis Testing, with expert answers to help guide accurate code selection and documentation.
Use these documentation templates to ensure complete and accurate documentation for Tuberculosis Testing. These templates include all required elements for proper coding and billing.
Need help with ICD-10 coding for Tuberculosis Testing? Ask your questions below.